ARAGEN
Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.
This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesize, profile, and then characterize a wide range of chemotypes against key targets of interest in swift optimization cycles. The partnership also allows for the integrated up-scaling of compounds for larger pre-clinical studies. Biology screening of appropriate chemical moieties to drive decision making with speed and accuracy is also included in the partnership. Aragen will dedicate a sizeable portion of its campus in Hyderabad to support this alliance.
"We at Aragen believe that ‘In Every Molecule is the Possibility for Better Health’, and are excited about the opportunity to expand our partnership with Boehringer Ingelheim, a global leader in the discovery and development of novel medicines. It has been our privilege to collaborate with the scientists at Boehringer Ingelheim, and we thank them for their trust and confidence in the Aragen team. Together, we look forward to advancing Boehringer Ingelheim’s innovative approaches into successful clinical outcomes that can have the potential to ultimately benefit patients,” said Manni Kantipudi, CEO at Aragen .
About Aragen
Aragen Life Sciences Pvt Ltd (“Aragen”) is a global leader in providing discovery, development and manufacturing solutions for life sciences firms. With a team of over 3100 professionals, and through a network of sites around the world, we offer a seamless, integrated platform to advance customer programs from discovery through commercialization for both small molecules and biologics. Established in 2001, Aragen now serves over 450 customers worldwide across multiple modalities and therapeutic areas. For more information, visit www.aragen.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210628005162/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Exstent Appoints Matt Thompson as CEO to Drive Global Growth in Personalised Aortic Support12.11.2025 08:04:00 CET | Press release
Exstent, a UK-based medical device company, developing personalised external aortic support to preserve the native aorta, today announced the appointment of Matt Thompson as Chief Executive Officer to lead its next phase of global growth. Matt brings more than two decades of combined clinical and commercial leadership to Exstent. He previously held leadership roles including President and CEO at Endologix, guiding the company through transformation, portfolio growth, and the 2021 acquisition of PQ Bypass. Earlier in his career, Matt was Professor of Vascular Surgery at St George’s Hospital, University of London, and Consultant Vascular Surgeon at St George’s Vascular Institute. His experience in integrating novel vascular technologies into established commercial frameworks aligns closely with Exstent’s strategic direction. “Exstent’s personalised external aortic support is a meaningful advance in managing ascending aortic disease,” said Matt Thompson, CEO of Exstent. “It preserves the
Ant International’s Antom Launches AI‑Powered MSME App for Finance and Business Operations12.11.2025 03:00:00 CET | Press release
The EPOS360 App integrates POS system, payments, banking, lending, and growth support into one platform to help MSMEs start, grow, and scale efficiently.The app embeds an AI copilot to simplify operations and turn business information into actionable insights.Supported by ANEXT Bank, one of the first digital banks in Singapore, MSMEs can access credit faster and manage financing with greater ease. Antom, a leading provider of merchant payment and digitisation services under Ant International, today announced EPOS360, an app that brings point-of-sale (POS) system, payments, banking, lending, and growth support together to help micro, small and medium-sized enterprises (MSMEs) move from setup to scale efficiently. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111066634/en/ The AI-powered EPOS360 provides POS system, payments, banking, lending and other growth-enabling services, offering customised support to help MSMEs ope
Venture Global and Mitsui Announce 20-Year LNG Sales and Purchase Agreement12.11.2025 00:00:00 CET | Press release
Venture Global’s third long-term contract with a Japanese company6.75 MTPA of long-term contracts signed by Venture Global to date in 2025 Today, Venture Global, Inc. (NYSE: VG) and Mitsui & Co., Ltd. of Japan announced the execution of a new, long-term liquefied natural gas (LNG) Sales and Purchase Agreement (SPA). Under the SPA, Mitsui will purchase 1.0 million tonnes per annum (MTPA) of LNG from Venture Global for 20 years, starting in 2029. “Venture Global is honored to announce our new partnership with Mitsui, a distinguished leader in the LNG industry, to further increase the flow of U.S. LNG to Japan and the global market,” said Mike Sabel, CEO of Venture Global. “This collaboration between our two companies will strengthen energy security, enhance the balance of trade, and deepen the long-standing ties between our nations. This agreement builds upon our existing long-term relationships with Japanese companies, and we are deeply grateful for their continued trust in Venture Glob
Lattice to Showcase Advanced Industrial and Edge AI Solutions at SPS 202511.11.2025 22:00:00 CET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced its participation in the upcoming SPS 2025, taking place on November 25 – 27, 2025 in Nuremberg, Germany. Lattice will deliver a presentation on secure motor control solutions and technology demonstrations with industry partners focused on advanced embedded vision and machine learning applications for the Industrial market. Who: Lattice Semiconductor What / When (GMT+2):Nov. 25 – 27, 2025: Embedded Vision and Machine Learning Demo Showcase EtherCAT Technology Group Booth (Hall 5, #310) Exor booth (Hall 9, #375) Nov. 25, 2025: Tech Talk (11 – 11:30 a.m.) Secure Connected Motion Control Platform for AC Motors: A Collaborative Innovation by Analog Devices and Lattice Semiconductor Where: Nuremberg Messe, Nuremberg, Germany SPS (Smart Product Solution) 2025 is one of the world’s leading trade fairs for industrial automation and digitalization. It showcases the entire spectrum of smart and digital autom
TOURISE Announces USD 113BN in Portfolio Investments to Accelerate the Future of Tourism11.11.2025 18:42:00 CET | Press release
High‑impact dealmaking at the inaugural TOURISE Summit catalyzes cross‑sector capital for growth across the global tourism ecosystem. TOURISE, the bold global platform shaping a new horizon for tourism, announced today that it has catalyzed investment portfolios totaling USD 113BN at the inaugural TOURISE Summit in Riyadh. The milestone reflects TOURISE’s mission to unlock high‑value deal flow by convening public and private sector leaders across tourism, technology, investment, and sustainability to set a shared roadmap for the next 50 years of global tourism. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111666032/en/ His Excellency Ahmed Al Khateeb, Saudi Arabia's Minister of Tourism and Chairman of TOURISE announces USD 113 BN of investment portfolios catalyzed at the inaugural TOURISE Summit. The announced portfolio investments span the full breadth of the visitor economy: luxury retail, next‑generation hotel accomm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom